AR092713A1 - Composiciones y metodos de uso de un compuesto para el control de la inapetencia - Google Patents
Composiciones y metodos de uso de un compuesto para el control de la inapetenciaInfo
- Publication number
- AR092713A1 AR092713A1 ARP130103486A ARP130103486A AR092713A1 AR 092713 A1 AR092713 A1 AR 092713A1 AR P130103486 A ARP130103486 A AR P130103486A AR P130103486 A ARP130103486 A AR P130103486A AR 092713 A1 AR092713 A1 AR 092713A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- capromorelin
- livestock
- syringe
- administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Feed For Specific Animals (AREA)
- Dermatology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261706164P | 2012-09-27 | 2012-09-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR092713A1 true AR092713A1 (es) | 2015-04-29 |
Family
ID=50339468
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130103486A AR092713A1 (es) | 2012-09-27 | 2013-09-27 | Composiciones y metodos de uso de un compuesto para el control de la inapetencia |
| ARP210102942A AR123902A2 (es) | 2012-09-27 | 2021-10-22 | Composición veterinaria oral para el control de inapetencia para un gato o un perro |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210102942A AR123902A2 (es) | 2012-09-27 | 2021-10-22 | Composición veterinaria oral para el control de inapetencia para un gato o un perro |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US11090292B2 (enExample) |
| EP (3) | EP2906041A4 (enExample) |
| JP (2) | JP6779618B2 (enExample) |
| KR (6) | KR20230097201A (enExample) |
| CN (2) | CN111419845A (enExample) |
| AR (2) | AR092713A1 (enExample) |
| AU (2) | AU2013323349B2 (enExample) |
| BR (1) | BR112015006282B1 (enExample) |
| CA (1) | CA2886091C (enExample) |
| DK (1) | DK3524260T3 (enExample) |
| ES (1) | ES2959427T3 (enExample) |
| MX (2) | MX2015003564A (enExample) |
| NZ (2) | NZ707174A (enExample) |
| PL (1) | PL3524260T3 (enExample) |
| PT (1) | PT3524260T (enExample) |
| RU (1) | RU2648958C2 (enExample) |
| TW (3) | TW202106298A (enExample) |
| WO (1) | WO2014052780A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20120131183A (ko) | 2010-02-26 | 2012-12-04 | 라퀄리아 파마 인코포레이티드 | 악액질 치료용 그렐린 수용체 작용제 |
| WO2013119800A1 (en) | 2012-02-07 | 2013-08-15 | Massachusetts Institute Of Technology | Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness |
| RU2648958C2 (ru) | 2012-09-27 | 2018-03-28 | Аратана Терапьютикс, Инк. | Композиции и способы применения соединения для борьбы с отсутствием аппетита |
| WO2014144231A1 (en) | 2013-03-15 | 2014-09-18 | Massachusetts Institute Of Technology | Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness |
| KR20180108916A (ko) * | 2015-01-28 | 2018-10-04 | 아라타나 세라퓨틱스, 인크. | 체중-증량 화합물의 장기 사용을 위한 조성물 및 방법 |
| WO2016138099A1 (en) | 2015-02-24 | 2016-09-01 | Massachusetts Institute Of Technology | Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness |
| AU2017358013B2 (en) * | 2016-11-11 | 2020-08-06 | Dsm Ip Assets B.V. | Compositions and methods of pet food |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US193273A (en) * | 1877-07-17 | Improvement in material for pulley-covers | ||
| JP2893901B2 (ja) * | 1990-09-07 | 1999-05-24 | 株式会社岐阜免疫研究所 | 動物用抗体含有油性ペースト製剤 |
| CA2095786A1 (en) * | 1992-05-08 | 1993-11-09 | Franco J. Vaccarino | Method of stimulating appetite |
| TW432073B (en) | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
| ATE446758T1 (de) | 2000-05-31 | 2009-11-15 | Pfizer Prod Inc | Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts |
| EP1181933A3 (en) * | 2000-06-29 | 2002-04-10 | Pfizer Products Inc. | Use of growth hormone secretagogues for stimulating or increasing appetite |
| US8309603B2 (en) * | 2004-06-07 | 2012-11-13 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| US7476653B2 (en) * | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
| US7491695B2 (en) * | 2003-06-18 | 2009-02-17 | Tranzyme Pharma Inc. | Methods of using macrocyclic modulators of the ghrelin receptor |
| US20080171700A1 (en) * | 2004-04-07 | 2008-07-17 | Gastrotech Pharma A/S | Use Of Secretagogue For The Teatment Of Ghrelin Deficiency |
| EP1812045A2 (en) * | 2004-10-27 | 2007-08-01 | Gastrotech Pharma A/S | Uses of secretagogues for treatment of organ transplant patients |
| EP1956923A1 (en) * | 2005-11-02 | 2008-08-20 | Nestec S.A. | Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use |
| CN101443358B (zh) * | 2006-03-13 | 2016-05-11 | 利亚特·明茨 | 生长素释放肽剪接变体在治疗恶病质和/或压食和/或厌食-恶病质和/或营养不良和/或脂肪营养障碍和/或肌肉消耗和/或刺激食欲中的用途 |
| ES2436419T3 (es) * | 2006-09-27 | 2014-01-02 | Ipsen Pharma S.A.S. | Análogos de ghrelina sustituidos en el N terminal |
| JP2008127377A (ja) * | 2006-11-24 | 2008-06-05 | Jichi Medical Univ | Ｇｈｓ−ｒ作動薬を含有してなるメタボリックシンドローム又は高血圧症の予防・治療剤。 |
| US20080226802A1 (en) * | 2007-03-14 | 2008-09-18 | Concentrate Manufacturing Company Of Ireland | Beverage having natural sweeteners with one or more stevia components and source of berry |
| TWI429436B (zh) * | 2007-04-10 | 2014-03-11 | Helsinn Therapeutics Us Inc | 使用生長激素促泌素治療或預防嘔吐之方法 |
| RU2007129408A (ru) * | 2007-07-31 | 2009-02-10 | Игорь Николаевич Жирков (RU) | Способ выращивания поросят в период откорма |
| FR2920295B1 (fr) * | 2007-09-05 | 2009-12-11 | Desvac | Dispositif d'injection de produits veterinaires a des volailles, comprenant un element de contention presentant une forme anatomique incluant des moyens de calage d'un os reperable |
| EP2215914B1 (en) * | 2007-11-12 | 2013-04-24 | San-Ei Gen F.F.I., INC. | Method of improving sweetness qualities of stevia extract |
| JP5552481B2 (ja) * | 2009-03-26 | 2014-07-16 | 武田薬品工業株式会社 | ピラゾール化合物 |
| KR20120131183A (ko) * | 2010-02-26 | 2012-12-04 | 라퀄리아 파마 인코포레이티드 | 악액질 치료용 그렐린 수용체 작용제 |
| RU2648958C2 (ru) | 2012-09-27 | 2018-03-28 | Аратана Терапьютикс, Инк. | Композиции и способы применения соединения для борьбы с отсутствием аппетита |
-
2013
- 2013-09-27 RU RU2015114996A patent/RU2648958C2/ru active
- 2013-09-27 KR KR1020237019962A patent/KR20230097201A/ko not_active Ceased
- 2013-09-27 AR ARP130103486A patent/AR092713A1/es not_active Application Discontinuation
- 2013-09-27 CN CN202010001164.1A patent/CN111419845A/zh active Pending
- 2013-09-27 KR KR1020217042990A patent/KR20220003640A/ko not_active Ceased
- 2013-09-27 WO PCT/US2013/062227 patent/WO2014052780A2/en not_active Ceased
- 2013-09-27 ES ES19161662T patent/ES2959427T3/es active Active
- 2013-09-27 KR KR1020217001509A patent/KR20210009438A/ko not_active Ceased
- 2013-09-27 PL PL19161662.2T patent/PL3524260T3/pl unknown
- 2013-09-27 TW TW109121986A patent/TW202106298A/zh unknown
- 2013-09-27 CA CA2886091A patent/CA2886091C/en active Active
- 2013-09-27 JP JP2015534747A patent/JP6779618B2/ja active Active
- 2013-09-27 US US14/039,114 patent/US11090292B2/en active Active
- 2013-09-27 DK DK19161662.2T patent/DK3524260T3/da active
- 2013-09-27 AU AU2013323349A patent/AU2013323349B2/en active Active
- 2013-09-27 KR KR1020157009647A patent/KR20150058345A/ko not_active Ceased
- 2013-09-27 EP EP13841455.2A patent/EP2906041A4/en not_active Withdrawn
- 2013-09-27 KR KR1020257009208A patent/KR20250048114A/ko active Pending
- 2013-09-27 CN CN201380061931.6A patent/CN105072909A/zh active Pending
- 2013-09-27 PT PT191616622T patent/PT3524260T/pt unknown
- 2013-09-27 BR BR112015006282-2A patent/BR112015006282B1/pt active IP Right Grant
- 2013-09-27 EP EP23191187.6A patent/EP4302825A3/en active Pending
- 2013-09-27 TW TW107142255A patent/TWI732158B/zh active
- 2013-09-27 TW TW102135177A patent/TWI667024B/zh active
- 2013-09-27 KR KR1020197037811A patent/KR20190143484A/ko not_active Ceased
- 2013-09-27 NZ NZ707174A patent/NZ707174A/en active IP Right Revival
- 2013-09-27 NZ NZ746394A patent/NZ746394A/en unknown
- 2013-09-27 EP EP19161662.2A patent/EP3524260B1/en active Active
- 2013-09-27 MX MX2015003564A patent/MX2015003564A/es active IP Right Grant
-
2015
- 2015-03-19 MX MX2022015141A patent/MX2022015141A/es unknown
-
2016
- 2016-08-22 AU AU2016216741A patent/AU2016216741B2/en active Active
-
2018
- 2018-03-07 JP JP2018041063A patent/JP6796097B2/ja active Active
-
2021
- 2021-10-22 AR ARP210102942A patent/AR123902A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR092713A1 (es) | Composiciones y metodos de uso de un compuesto para el control de la inapetencia | |
| EA201790568A1 (ru) | Применение двойного агониста рецепторов glp-1/глюкагона пролонгированного действия для лечения неалкогольной жировой болезни печени | |
| BRPI0922552A2 (pt) | Inibidores de piridiloxiindóis de vegf-r2 e seu uso, composição e combinação farmacêuticas, e kit | |
| EA201100896A1 (ru) | Композиция, предназначенная для всасывания никотина из ротовой полости с целью прекратить курение | |
| BR112012023139A2 (pt) | composição farmacêutica para a prevenção ou o tratamento de doença do fígado gordo não alcóolico e o método para a prevenção ou tratamento de doença do fígado gordo não alcóolico usando a mesma. | |
| PE20160194A1 (es) | Composiciones y metodos para tratar anemia | |
| BR112013020802A2 (pt) | métodos e composições para tratar, reduzir ou impedir dano ao sistema nervoso de animais | |
| MX2019007779A (es) | Metodo cosmetico para el tratamiento o reduccion de paniculopatia edemato-fibroesclerotica (pefe). | |
| MX376210B (es) | Uso de derivados de isoxazolina para el tratamiento o prevención de infestaciones por artrópodos en aves de corral. | |
| BR112016024020A8 (pt) | composição farmacêutica | |
| GB2523707A (en) | Novel pharmaceutical formulations and their use in the treatment of periodontal disease | |
| CO2019004004A2 (es) | Composición farmacéutica y método para el tratamiento de la enfermedad del hígado graso no alcohólico | |
| MX2019006773A (es) | Dexmedetomidina o medetomidina para uso en el tratamiento de la ansiedad por separacion en perros. | |
| BR112012020377A8 (pt) | utilização de um ou mais selecionado do grupo constituído por um composto da fórmula (i), uma mistura racêmica-diastereomérica e um isômero óptico do referido composto, e um sal farmaceuticamente aceitável e uma pródroga do mesmo, método, composição farmacêutica e kit para tratamento de caquexia e embalagem comercial | |
| BR112018077032A2 (pt) | método para aprimorar o crescimento ou a conversão alimentar em um animal, uso de pgn, mdp ou um análogo de mdp na preparação de um medicamento e pgn, mdp ou um análogo de mdp | |
| BR112013016554A2 (pt) | métodos e composições úteis para promover sono nos animais | |
| AR103555A1 (es) | Composiciones y métodos para el uso crónico de un compuesto para aumentar el peso | |
| BR112017001589A2 (pt) | peptídeos marinhos e nucleotídeos de peixe, composições e usos dos mesmos para reduzir a glicose no sangue | |
| ECSP19000167A (es) | Métodos y composiciones para el tratamiento de la hipercalciuria y la nefrolitiasis | |
| EA201590097A1 (ru) | Составы с однократной дозой для перорального введения и способы лечения кошек с помощью спиносада, уничтожающего эктопаразитов | |
| DOP2013000004A (es) | Agentes terapeuticos 976 | |
| RU2011108858A (ru) | Средство для повышения роста и сохранности молодняка | |
| AR128434A2 (es) | Composiciones y métodos de absorción transmucosa | |
| AR130948A2 (es) | Composiciones y métodos para el tratamiento de la anemia | |
| MD408Z (ro) | Procedeu de profilaxie şi tratament al ectoparazitozei la găini |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |